株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

遺伝子治療の世界市場

Gene Therapy

発行 Global Industry Analysts, Inc. 商品コード 912405
出版日 ページ情報 英文 183 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.71円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
遺伝子治療の世界市場 Gene Therapy
出版日: 2019年10月01日 ページ情報: 英文 183 Pages
概要

当レポートでは、世界における遺伝子治療市場の概要、動向・発展への影響因子の分析、競合企業と市場シェア、世界および地域・主要国別の市場規模の推移と予測、主要企業のプロファイルなどをまとめています。

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
    • 世界市場における企業シェア
    • 世界市場における企業シェアのシナリオ
  • 主要企業
  • 市場の動向と発展因子
  • 世界市場の見通し

第3章 市場分析

  • 地域別市場の分析
    • 米国
    • カナダ
    • 日本
    • 中国
    • 欧州
    • フランス
    • ドイツ
    • イタリア
    • 英国
    • スペイン
    • ロシア
    • その他欧州
    • アジア太平洋地域
    • オーストラリア
    • インド
    • 韓国
    • その他アジア太平洋地域
    • ラテンアメリカ
    • アルゼンチン
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ
    • 中東
    • イラン
    • イスラエル
    • サウジアラビア
    • アラブ首長国連邦
    • その他中東
    • アフリカ

第4章 競合企業

  • AMERICAN GENE TECHNOLOGIES INC.
  • APPLIED GENETIC TECHNOLOGIES CORPORATION
  • BENITEC BIOPHARMA
  • BIOMARIN PHARMACEUTICAL
  • BLUEBIRD BIO
  • BRAMMER BIO
  • BRISTOL-MYERS SQUIBB COMPANY
  • CELGENE CORPORATION
  • CELLECTIS
  • CELLFORCURE
  • CEVEC PHARMACEUTICALS GMBH
  • CHIESI FARMACEUTICI SPA
  • CSL BEHRING
  • GENSIGHT BIOLOGICS S.A.
  • GILEAD SCIENCES
  • GLAXOSMITHKLINE PLC
  • HUMAN STEM CELLS INSTITUTE PJSC (HSCI)
  • JUNO THERAPEUTICS, INC.
  • LONZA GROUP AG
  • NOVARTIS INTERNATIONAL AG
  • NOVASEP HOLDING SAS
  • OXFORD BIOMEDICA PLC
  • REGENXBIO
  • SANOFI GENZYME
  • SHANGHAI SUNWAY BIOTECH
  • SHENZHEN SIBIONO GENETECH
  • SHIRE PLC
  • TAXUS CARDIUM PHARMACEUTICALS GROUP
  • TRANSGENE SA
  • ULTRAGENYX PHARMACEUTICAL
  • UNIQURE NV
  • VOYAGER THERAPEUTICS

第5章 調査資料

目次
Product Code: MCP-1127

Gene Therapy market worldwide is projected to grow by US$3.3 Billion, driven by a compounded growth of 32.7%. Lentivirus, one of the segments analyzed and sized in this study, displays the potential to grow at over 25.3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$125.3 Million by the year 2025, Lentivirus will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 30% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$133.3 Million to the region's size and clout in the next 5 to 6 years. Over US$117.2 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Lentivirus will reach a market size of US$6.5 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 39.2% over the next couple of years and add approximately US$797 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,, American Gene Technologies Inc.; Applied Genetic Technologies Corporation; Benitec BioPharma; BioMarin Pharmaceutical, Inc.; bluebird bio, Inc.; Brammer Bio; Bristol-Myers Squibb Company; Celgene Corporation; Cellectis; CELLforCURE; CEVEC Pharmaceuticals GmbH; Chiesi Farmaceutici SpA; CSL Behring; Gensight Biologics S.A.; Gilead Sciences, Inc.; GlaxoSmithKline PLC; Human Stem Cells Institute PJSC (HSCI); Juno Therapeutics, Inc.; Lonza Group Ltd.; Novartis International AG; Novasep Holding SAS; Orchard Therapeutics Ltd.; Oxford Biomedica plc; REGENXBIO, Inc.; Sanofi Genzyme; Shanghai Sunway Biotech Co., Ltd.; Shenzhen SiBiono GeneTech Co., Ltd.; Shire PLC; Taxus Cardium Pharmaceuticals Group; Transgene SA; Ultragenyx Pharmaceutical, Inc.; uniQure NV; Voyager Therapeutics, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Gene Therapy Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Gene Therapy Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025
  • TABLE 2: Gene Therapy Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2009-2017
  • TABLE 3: Gene Therapy Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Lentivirus (Vector) World Market by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 5: Lentivirus (Vector) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 6: Lentivirus (Vector) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: AAV (Vector) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025
  • TABLE 8: AAV (Vector) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 9: AAV (Vector) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 10: RetroVirus & Gamma RetroVirus (Vector) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025
  • TABLE 11: RetroVirus & Gamma RetroVirus (Vector) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017
  • TABLE 12: RetroVirus & Gamma RetroVirus (Vector) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: Modified Herpes Simplex Virus (Vector) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 14: Modified Herpes Simplex Virus (Vector) Market Historic Review by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 15: Modified Herpes Simplex Virus (Vector) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 16: Adenovirus (Vector) World Market by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 17: Adenovirus (Vector) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 18: Adenovirus (Vector) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 19: Other Applications (Vector) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018 to 2025
  • TABLE 20: Other Applications (Vector) Market Worldwide Historic Review by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 21: Other Applications (Vector) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Gene Therapy Market Share (in %) by Company: 2019 & 2025
    • TABLE 22: United States Gene Therapy Market Estimates and Projections in US$ Thousand by Vector: 2018 to 2025
    • TABLE 23: Gene Therapy Market in the United States by Vector: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 24: United States Gene Therapy Market Share Breakdown by Vector: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 25: Canadian Gene Therapy Market Estimates and Forecasts in US$ Thousand by Vector: 2018 to 2025
    • TABLE 26: Canadian Gene Therapy Historic Market Review by Vector in US$ Thousand: 2009-2017
    • TABLE 27: Gene Therapy Market in Canada: Percentage Share Breakdown of Sales by Vector for 2009, 2019, and 2025
  • JAPAN
    • TABLE 28: Japanese Market for Gene Therapy: Annual Sales Estimates and Projections in US$ Thousand by Vector for the Period 2018-2025
    • TABLE 29: Gene Therapy Market in Japan: Historic Sales Analysis in US$ Thousand by Vector for the Period 2009-2017
    • TABLE 30: Japanese Gene Therapy Market Share Analysis by Vector: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 31: Chinese Gene Therapy Market Growth Prospects in US$ Thousand by Vector for the Period 2018-2025
    • TABLE 32: Gene Therapy Historic Market Analysis in China in US$ Thousand by Vector: 2009-2017
    • TABLE 33: Chinese Gene Therapy Market by Vector: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Gene Therapy Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 34: European Gene Therapy Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025
    • TABLE 35: Gene Therapy Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2009-2017
    • TABLE 36: European Gene Therapy Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 37: European Gene Therapy Market Estimates and Forecasts in US$ Thousand by Vector: 2018-2025
    • TABLE 38: Gene Therapy Market in Europe in US$ Thousand by Vector: A Historic Review for the Period 2009-2017
    • TABLE 39: European Gene Therapy Market Share Breakdown by Vector: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 40: Gene Therapy Market in France by Vector: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 41: French Gene Therapy Historic Market Scenario in US$ Thousand by Vector: 2009-2017
    • TABLE 42: French Gene Therapy Market Share Analysis by Vector: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 43: Gene Therapy Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Vector for the Period 2018-2025
    • TABLE 44: German Gene Therapy Historic Market Analysis in US$ Thousand by Vector: 2009-2017
    • TABLE 45: German Gene Therapy Market Share Breakdown by Vector: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 46: Italian Gene Therapy Market Growth Prospects in US$ Thousand by Vector for the Period 2018-2025
    • TABLE 47: Gene Therapy Historic Market Analysis in Italy in US$ Thousand by Vector: 2009-2017
    • TABLE 48: Italian Gene Therapy Market by Vector: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 49: United Kingdom Market for Gene Therapy: Annual Sales Estimates and Projections in US$ Thousand by Vector for the Period 2018-2025
    • TABLE 50: Gene Therapy Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Vector for the Period 2009-2017
    • TABLE 51: United Kingdom Gene Therapy Market Share Analysis by Vector: 2009 VS 2019 VS 2025
  • SPAIN
    • TABLE 52: Spanish Gene Therapy Market Estimates and Forecasts in US$ Thousand by Vector: 2018 to 2025
    • TABLE 53: Spanish Gene Therapy Historic Market Review by Vector in US$ Thousand: 2009-2017
    • TABLE 54: Gene Therapy Market in Spain: Percentage Share Breakdown of Sales by Vector for 2009, 2019, and 2025
  • RUSSIA
    • TABLE 55: Russian Gene Therapy Market Estimates and Projections in US$ Thousand by Vector: 2018 to 2025
    • TABLE 56: Gene Therapy Market in Russia by Vector: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 57: Russian Gene Therapy Market Share Breakdown by Vector: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 58: Rest of Europe Gene Therapy Market Estimates and Forecasts in US$ Thousand by Vector: 2018-2025
    • TABLE 59: Gene Therapy Market in Rest of Europe in US$ Thousand by Vector: A Historic Review for the Period 2009-2017
    • TABLE 60: Rest of Europe Gene Therapy Market Share Breakdown by Vector: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 61: Asia-Pacific Gene Therapy Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025
    • TABLE 62: Gene Therapy Market in Asia-Pacific: Historic Market Analysis in US$ Thousand by Region/Country for the Period 2009-2017
    • TABLE 63: Asia-Pacific Gene Therapy Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 64: Gene Therapy Market in Asia-Pacific by Vector: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 65: Asia-Pacific Gene Therapy Historic Market Scenario in US$ Thousand by Vector: 2009-2017
    • TABLE 66: Asia-Pacific Gene Therapy Market Share Analysis by Vector: 2009 VS 2019 VS 2025
  • AUSTRALIA
    • TABLE 67: Gene Therapy Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Vector for the Period 2018-2025
    • TABLE 68: Australian Gene Therapy Historic Market Analysis in US$ Thousand by Vector: 2009-2017
    • TABLE 69: Australian Gene Therapy Market Share Breakdown by Vector: 2009 VS 2019 VS 2025
  • INDIA
    • TABLE 70: Indian Gene Therapy Market Estimates and Forecasts in US$ Thousand by Vector: 2018 to 2025
    • TABLE 71: Indian Gene Therapy Historic Market Review by Vector in US$ Thousand: 2009-2017
    • TABLE 72: Gene Therapy Market in India: Percentage Share Breakdown of Sales by Vector for 2009, 2019, and 2025
  • SOUTH KOREA
    • TABLE 73: Gene Therapy Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Vector for the Period 2018-2025
    • TABLE 74: South Korean Gene Therapy Historic Market Analysis in US$ Thousand by Vector: 2009-2017
    • TABLE 75: Gene Therapy Market Share Distribution in South Korea by Vector: 2009 VS 2019 VS 2025
  • REST OF ASIA-PACIFIC
    • TABLE 76: Rest of Asia-Pacific Market for Gene Therapy: Annual Sales Estimates and Projections in US$ Thousand by Vector for the Period 2018-2025
    • TABLE 77: Gene Therapy Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Vector for the Period 2009-2017
    • TABLE 78: Rest of Asia-Pacific Gene Therapy Market Share Analysis by Vector: 2009 VS 2019 VS 2025
  • LATIN AMERICA
    • TABLE 79: Latin American Gene Therapy Market Trends by Region/Country in US$ Thousand: 2018-2025
    • TABLE 80: Gene Therapy Market in Latin America in US$ Thousand by Region/Country: A Historic Perspective for the Period 2009-2017
    • TABLE 81: Latin American Gene Therapy Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
    • TABLE 82: Latin American Gene Therapy Market Growth Prospects in US$ Thousand by Vector for the Period 2018-2025
    • TABLE 83: Gene Therapy Historic Market Analysis in Latin America in US$ Thousand by Vector: 2009-2017
    • TABLE 84: Latin American Gene Therapy Market by Vector: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • ARGENTINA
    • TABLE 85: Argentinean Gene Therapy Market Estimates and Forecasts in US$ Thousand by Vector: 2018-2025
    • TABLE 86: Gene Therapy Market in Argentina in US$ Thousand by Vector: A Historic Review for the Period 2009-2017
    • TABLE 87: Argentinean Gene Therapy Market Share Breakdown by Vector: 2009 VS 2019 VS 2025
  • BRAZIL
    • TABLE 88: Gene Therapy Market in Brazil by Vector: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 89: Brazilian Gene Therapy Historic Market Scenario in US$ Thousand by Vector: 2009-2017
    • TABLE 90: Brazilian Gene Therapy Market Share Analysis by Vector: 2009 VS 2019 VS 2025
  • MEXICO
    • TABLE 91: Gene Therapy Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Vector for the Period 2018-2025
    • TABLE 92: Mexican Gene Therapy Historic Market Analysis in US$ Thousand by Vector: 2009-2017
    • TABLE 93: Mexican Gene Therapy Market Share Breakdown by Vector: 2009 VS 2019 VS 2025
  • REST OF LATIN AMERICA
    • TABLE 94: Rest of Latin America Gene Therapy Market Estimates and Projections in US$ Thousand by Vector: 2018 to 2025
    • TABLE 95: Gene Therapy Market in Rest of Latin America by Vector: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 96: Rest of Latin America Gene Therapy Market Share Breakdown by Vector: 2009 VS 2019 VS 2025
  • MIDDLE EAST
    • TABLE 97: The Middle East Gene Therapy Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025
    • TABLE 98: Gene Therapy Market in the Middle East by Region/Country in US$ Thousand: 2009-2017
    • TABLE 99: The Middle East Gene Therapy Market Share Breakdown by Region/Country: 2009, 2019, and 2025
    • TABLE 100: The Middle East Gene Therapy Market Estimates and Forecasts in US$ Thousand by Vector: 2018 to 2025
    • TABLE 101: The Middle East Gene Therapy Historic Market by Vector in US$ Thousand: 2009-2017
    • TABLE 102: Gene Therapy Market in the Middle East: Percentage Share Breakdown of Sales by Vector for 2009, 2019, and 2025
  • IRAN
    • TABLE 103: Iranian Market for Gene Therapy: Annual Sales Estimates and Projections in US$ Thousand by Vector for the Period 2018-2025
    • TABLE 104: Gene Therapy Market in Iran: Historic Sales Analysis in US$ Thousand by Vector for the Period 2009-2017
    • TABLE 105: Iranian Gene Therapy Market Share Analysis by Vector: 2009 VS 2019 VS 2025
  • ISRAEL
    • TABLE 106: Israeli Gene Therapy Market Estimates and Forecasts in US$ Thousand by Vector: 2018-2025
    • TABLE 107: Gene Therapy Market in Israel in US$ Thousand by Vector: A Historic Review for the Period 2009-2017
    • TABLE 108: Israeli Gene Therapy Market Share Breakdown by Vector: 2009 VS 2019 VS 2025
  • SAUDI ARABIA
    • TABLE 109: Saudi Arabian Gene Therapy Market Growth Prospects in US$ Thousand by Vector for the Period 2018-2025
    • TABLE 110: Gene Therapy Historic Market Analysis in Saudi Arabia in US$ Thousand by Vector: 2009-2017
    • TABLE 111: Saudi Arabian Gene Therapy Market by Vector: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED ARAB EMIRATES
    • TABLE 112: Gene Therapy Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Vector for the Period 2018-2025
    • TABLE 113: United Arab Emirates Gene Therapy Historic Market Analysis in US$ Thousand by Vector: 2009-2017
    • TABLE 114: Gene Therapy Market Share Distribution in United Arab Emirates by Vector: 2009 VS 2019 VS 2025
  • REST OF MIDDLE EAST
    • TABLE 115: Gene Therapy Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Vector for the Period 2018-2025
    • TABLE 116: Rest of Middle East Gene Therapy Historic Market Analysis in US$ Thousand by Vector: 2009-2017
    • TABLE 117: Rest of Middle East Gene Therapy Market Share Breakdown by Vector: 2009 VS 2019 VS 2025
  • AFRICA
    • TABLE 118: African Gene Therapy Market Estimates and Projections in US$ Thousand by Vector: 2018 to 2025
    • TABLE 119: Gene Therapy Market in Africa by Vector: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 120: African Gene Therapy Market Share Breakdown by Vector: 2009 VS 2019 VS 2025

IV. COMPETITION

  • AMERICAN GENE TECHNOLOGIES INC.
  • APPLIED GENETIC TECHNOLOGIES CORPORATION
  • BENITEC BIOPHARMA
  • BIOMARIN PHARMACEUTICAL
  • BLUEBIRD BIO
  • BRAMMER BIO
  • BRISTOL-MYERS SQUIBB COMPANY
  • CELGENE CORPORATION
  • CELLECTIS
  • CELLFORCURE
  • CEVEC PHARMACEUTICALS GMBH
  • CHIESI FARMACEUTICI SPA
  • CSL BEHRING
  • GENSIGHT BIOLOGICS S.A.
  • GILEAD SCIENCES
  • GLAXOSMITHKLINE PLC
  • HUMAN STEM CELLS INSTITUTE PJSC (HSCI)
  • JUNO THERAPEUTICS, INC.
  • LONZA GROUP AG
  • NOVARTIS INTERNATIONAL AG
  • NOVASEP HOLDING SAS
  • OXFORD BIOMEDICA PLC
  • REGENXBIO
  • SANOFI GENZYME
  • SHANGHAI SUNWAY BIOTECH
  • SHENZHEN SIBIONO GENETECH
  • SHIRE PLC
  • TAXUS CARDIUM PHARMACEUTICALS GROUP
  • TRANSGENE SA
  • ULTRAGENYX PHARMACEUTICAL
  • UNIQURE NV
  • VOYAGER THERAPEUTICS

V. CURATED RESEARCH

Back to Top